Concluding Thoughts on the Treatment of Dry Eye Disease

EP: 1.Overview of Dry Eye Disease (DED) Causes and Treatments

EP: 2.Adverse Events & Existing Treatment Options for Dry Eye Disease

EP: 3.Navigating Different Subtypes of Dry Eye Disease

EP: 4.Assessing Efficacy of Treatment Through Patient-Reported Outcomes

EP: 5.Updating Formularies: Considerations for Dry Eye Disease

EP: 6.Assessing the Economic Burden of Under Diagnosed Dry Eye Disease

EP: 7.Identifying Key Socioeconomic Burdens Associated with Dry Eye Disease

EP: 8.Resource Allocation in the Treatment of Dry Eye Disease

EP: 9.Quality of Life & Patient Reported Outcomes in Dry Eye Disease

EP: 10.Annual Health Care Costs of Managing Dry Eye Disease

EP: 11.Novel Treatments Targeting Symptoms & Causes of Dry Eye Disease

EP: 12.Evaluating Treatment Outcomes in Dry Eye Disease

EP: 13.Evaluating Economic Impact of Emerging Therapies for Dry Eye Disease

Now Viewing

EP: 14.Concluding Thoughts on the Treatment of Dry Eye Disease

This is a video synopsis/summary of a Stakeholder Summit involving:

Ryan Haumschild, PharmD, MS, MBA; Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD.

Haumschild asks about primary obstacles reducing dry eye disease (DED) treatment effectiveness. Parekh states providers are diagnosing DED, preferred practice guidelines are evolving, and industry innovation continues. However, insurance barriers such as step therapy protocols remain frustrating despite expanding options. This leads to communication breakdowns with patients wrongly ascribing access issues to their provider. He urges payers to demand evidence of efficacy but facilitate access so comprehensive DED care is achievable for every patient subtype. As DED progresses untreated, exponentially costlier specialized treatments become necessary. Early intervention optimizes value.

In concluding key takeaways for stakeholders, Kabiri advocates embracing innovation benefiting large patient subgroups that lowers long-term disease costs. Parekh foresees targeted DED therapies matched to specific deficiencies at the right timepoints with better coverage as the ideal future landscape through continued collaboration across stakeholders to fulfill unmet needs.

Video synopsis is AI-generated and reviewed by AJMCÒ editorial staff.